People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Omnimmune Holdings, Inc. | — | Biotechnology | Pre-Seed | $200K | $11.0M | 2010 |
Charles A. Duff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles A. Duff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark S. Germain | 1 | 2 |
| Matthew A Gonda | 1 | 2 |
| Alexander A. Krichevsky | 1 | 1 |
| Howard A. Becker | 1 | 1 |
| Harris A. Lichtenstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.